AlphaYou
Overview
Smart money at a glance
Filings to Oct 9, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 8- Open
- $31.03
- 52-wk high
- $44.00
- High
- $31.22
- 52-wk low
- $19.50
- Low
- $29.80
- Prev close
- $31.01
- Mkt cap
- $118.7M
- Volume
- 44.3K
- Beta
- 0.21
- P/S
- 3.2x
- P/B
- 1.5x
- Profit margin
- -12.9%
- Op margin
- -25.1%
- ROE
- -15.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about VTVT filings
Are insiders buying or selling vTv Therapeutics Inc (VTVT) stock?
Neither. vTv Therapeutics Inc (VTVT) insiders filed no open-market purchases or sales in the 90 days to Oct 9, 2026, according to SEC Form 4 filings.
Which members of Congress have traded VTVT recently?
None. No member of Congress disclosed a VTVT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this VTVT smart-money data?
This summary uses filings available on Oct 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
How top traders are positioned
No tracked top-trader positions in VTVT right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 5, 2026, in 27 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -12.9%
- Market cap
- $119M
Valuation
- P/S3.22
- P/B1.54
Quality
- Operating margin-25.1%
- ROE-15.8%
- ROA-10.1%
Growth
- Beta0.21
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace